Verastem (VSTM) Gains from Investment Securities (2023 - 2026)

Verastem's (VSTM) quarterly Gains from Investment Securities came in at -$9.3 million in Q1 2026, down 485.89% year-on-year from $2.4 million in Q1 2025, and up 11.08% quarter-over-quarter from -$10.5 million in Q4 2025.

Verastem (VSTM) Gains from Investment Securities (2023 - 2026) Analysis & Trends

Verastem's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$9.3 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 485.89% year-over-year to -$9.3 million in Q1 2026; TTM through Mar 2026 was $15.8 million, a 72.37% decrease from a year earlier, with the FY2025 full-year figure at $27.5 million, up 43.57% from the prior year.
  • Gains from Investment Securities rose to -$9.3 million in Q1 2026 per VSTM's latest filing, from -$10.5 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $55.9 million in Q3 2025 and bottomed at -$20.3 million in Q2 2025.
  • The 4-year median for Gains from Investment Securities is $5.5 million (2023), against an average of $9.1 million.
  • Across the five-year window, Gains from Investment Securities soared 313.93% in 2025 and tumbled 485.89% in 2026, its largest moves.
  • Year by year, Gains from Investment Securities stood at $8.5 million in 2023, then jumped by 284.08% to $32.6 million in 2024, then plunged by 132.16% to -$10.5 million in 2025, then increased by 11.08% to -$9.3 million in 2026.
  • Per Business Quant, the three latest VSTM Gains from Investment Securities figures stand at -$9.3 million (Q1 2026), -$10.5 million (Q4 2025), and $55.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Verastem 607.94 Mn 410.11 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.32 Mn
Mar 31, 2026 -9.32 Mn
Dec 31, 2025 -10.49 Mn
Dec 31, 2025 -10.49 Mn
Sep 30, 2025 55.88 Mn
Sep 30, 2025 55.88 Mn
Jun 30, 2025 -20.32 Mn
Jun 30, 2025 -20.32 Mn
Mar 31, 2025 2.42 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 32.61 Mn
Dec 31, 2024 32.61 Mn
Sep 30, 2024 13.50 Mn
Sep 30, 2024 13.50 Mn
Jun 30, 2023 8.49 Mn
Jun 30, 2023 8.49 Mn